Caffeine as a Therapy for Parkinson's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

May 1, 2016

Study Completion Date

December 1, 2016

Conditions
Parkinson's Disease
Interventions
DRUG

Caffeine

DRUG

Placebo

Trial Locations (8)

80240-021

Parana Parkinson Association - Pontifical Catholic University of Parana, Curitiba

T2N 4Z6

Heritage Medical Research Clinic - University of Calgary, Calgary

V6T 2B5

UBC Hospital - Pacific Parkinson's Research Centre, Vancouver

R3J 2H7

Movement Disorder Clinic - Deer Lodge Centre, Winnipeg

A1B 3V6

Memorial University of Newfoundland, St. John's

K1Y 4E9

The Ottawa Hospital - Civic Campus, Ottawa

M5T 2S8

Toronto western Hospital - Movement Disorders Research Centre, Toronto

H3G 1A4

McGill University Health Center, Montreal

All Listed Sponsors
collaborator

Pontifícia Universidade Católica do Paraná

OTHER

collaborator

University of Calgary

OTHER

collaborator

University of Newfoundland and Eastern Health

UNKNOWN

collaborator

University Health Network, Toronto

OTHER

collaborator

UBC Hospital

UNKNOWN

collaborator

Movement Disorder Clinic - Deer Lodge Centre

UNKNOWN

collaborator

The Ottawa Hospital

OTHER

lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

NCT01738178 - Caffeine as a Therapy for Parkinson's Disease | Biotech Hunter | Biotech Hunter